Vimarsana
Biggest News Aggregation in the World

Page 6 - Neuraxis Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Neuraxis Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Neuraxis Inc Today - Breaking & Trending Today

Analyst Models NeurAxis 12-Month Share Price Target At $14, 301% Higher Than Current Price ($NRXS) - Vimarsana News

Analyst Models NeurAxis 12-Month Share Price Target At $14, 301% Higher Than Current Price ($NRXS)

Having just 1.21 million outstanding shares typically presents exceptionally well to a growth stock investor. But while it can fuel appreciable gains quickly, it can also cause downward pressure....

EXCLUSIVE: NeurAxis' Nerve Field Stimulation Tech Shows Improved Quality of Life of Adolescents Patients With Irritable Bowel Syndrome - Neuraxis (AMEX:NRXS) - Vimarsana News

EXCLUSIVE: NeurAxis' Nerve Field Stimulation Tech Shows Improved Quality of Life of Adolescents Patients With Irritable Bowel Syndrome - Neuraxis (AMEX:NRXS)

NeurAxis Inc (NYSE: NRXS) announced the publication of a Prospective study evaluating the efficacy of IB-Stim in children featured in the September 2023 Frontiers in Pain Research.

EXCLUSIVE: NeurAxis' Nerve Field Stimulation Tech Shows Improved Quality of Life of Adolescents Patients With Irritable Bowel Syndrome - Vimarsana News

EXCLUSIVE: NeurAxis' Nerve Field Stimulation Tech Shows Improved Quality of Life of Adolescents Patients With Irritable Bowel Syndrome

NeurAxis Inc (NYSE: NRXS) announced the publication of a Prospective study evaluating the efficacy of IB-Stim in children featured in the September 2023 Frontiers in Pain Research. The publication investigated changes in gastrointestinal symptoms and quality of life in 31 adolescent patients aged 11 – 18 years with functional abdominal pain disorders (FAPDs) before and after treatment with IB-Stim. Also Read: EXCLUSIVE: Small MedTech Firm NeurAxis Targets $2B Market With Post-Concussion Therapy

Source: yahoo.com
Why CS Disco Are Trading Lower By 22%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session - Aurora Cannabis (NASDAQ:ACB), AgileThought (NASDAQ:AGIL) - Vimarsana News

Why CS Disco Are Trading Lower By 22%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session - Aurora Cannabis (NASDAQ:ACB), AgileThought (NASDAQ:AGIL)

Gainers Tenon Medical, Inc. (NASDAQ: TNON) shares climbed 63.5% to $0.2351 after the company announced it has withdrawn its proposed public offering of shares of its common stock.

NeurAxis Looks To Revolutionize The Treatment Of Adolescent Stomach Issues - Vimarsana News

NeurAxis Looks To Revolutionize The Treatment Of Adolescent Stomach Issues

NeurAxis, Inc. (NYSEAMERICAN: NRXS) looks to revolutionize how pediatric irritable bowel syndrome (IBS) and functional abdominal pain (FAP) are treated.